The clinical effectiveness and cost-effectiveness of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C in children and young people: a systematic review and economic evaluation.

BACKGROUND: Optimal therapy for children with chronic hepatitis C is unclear. Two treatment regimens are currently licensed in children. OBJECTIVES: To assess the clinical effectiveness and cost-effectiveness of peginterferon alfa-2a (Pegasys®, Roche) and peginterferon alfa-2b [ViraferonPeg®, Merck...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Health Technol Assess
Main Authors: Hartwell, Debbie, Cooper, Keith, Frampton, Geoff K, Baxter, Louise, Loveman, Emma
Format: Artigo
Jezik:Inglês
Izdano: NIHR Journals Library 2014
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4781090/
https://ncbi.nlm.nih.gov/pubmed/25350588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta18650
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki